Roche (RHHBY) announced the FDA approval of a label expansion into biliary tract cancer, or BTC, for the Pathway anti-HER2/neu Rabbit ...

Roche (RHHBY) announced that the U.S. Food and Drug Administration has approved an expansion of the PATHWAY anti-HER2/neu (4B5) ...

Jazz Pharmaceuticals (JAZZ) stock and Zymeworks (ZYME) stock gain as FDA clears their cancer therapy Ziihera. Read more here.

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

Tesla’s Model 3 ranked last in a German reliability study of newer cars for the second year. The report found a high ...

The US Food and Drug Administration (FDA) has granted accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for ...

Knicks at Nuggets, Monday, November 25, 2024, 9 pm ET The Knicks are set to face the Denver Nuggets in the lofty Ball Arena on Monday. On Saturday, New York missed a chance to improve upon their ...

US FDA approves Jazz Pharma’s Ziihera to treat adults with previously treated, unresectable or metastatic HER2-positive biliary tract cancer: Dublin Friday, November 22, 2024, 1 ...

Last night, one of the popular Jeopardy! categories was 'Broadway Musicals by Songs'  Several clues were given to the ...

Rev. Johnson, who also was a Baptist minister, was "a compassionate empathic person," said Craig Mustard, his longtime cohost ...

Los Angeles Lakers rookie small forward, Dalton Knecht, is making a very early Rookie of the Year case with his recent performance.

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.